179 related articles for article (PubMed ID: 26248711)
1. Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study.
Harouna AM; Amorissani-Folquet M; Eboua FT; Desmonde S; N'Gbeche S; Aka EA; Kouadio K; Kouacou B; Malateste K; Bosse-Amani C; Ahuatchi Coffie P; Leroy V;
BMC Infect Dis; 2015 Aug; 15():317. PubMed ID: 26248711
[TBL] [Abstract][Full Text] [Related]
2. 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.
Harambat J; Fassinou P; Becquet R; Touré P; Rouet F; Dabis F; Msellati P; Blanche S; Timité-Konan M; Salamon R; Leroy V;
BMC Public Health; 2008 May; 8():169. PubMed ID: 18492259
[TBL] [Abstract][Full Text] [Related]
3. Health care resource utilization in untreated HIV-infected children in a pediatric programme, Abidjan, Côte d'Ivoire, 2004-2009.
Desmonde S; Coffie PA; Aka EA; Amani-Bosse C; Messou E; Dabis F; Ciaranello A; Leroy V
J Acquir Immune Defic Syndr; 2013 Jan; 62(1):e14-21. PubMed ID: 23262977
[TBL] [Abstract][Full Text] [Related]
4. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.
Losina E; Yazdanpanah Y; Deuffic-Burban S; Wang B; Wolf LL; Messou E; Gabillard D; Seyler C; Freedberg KA; Anglaret X
Antivir Ther; 2007; 12(4):543-51. PubMed ID: 17668563
[TBL] [Abstract][Full Text] [Related]
5. Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009.
Desmonde S; Coffie P; Aka E; Amani-Bosse C; Messou E; Dabis F; Alioum A; Ciaranello A; Leroy V
BMC Infect Dis; 2011 Jun; 11():182. PubMed ID: 21699728
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.
Ndondoki C; Dicko F; Ahuatchi Coffie P; Kassi Eboua T; Ekouevi DK; Kouadio K; Edmond Aka A; Malateste K; Dabis F; Amani-Bosse C; Toure P; Leroy V;
J Int AIDS Soc; 2014; 17(1):18737. PubMed ID: 24894377
[TBL] [Abstract][Full Text] [Related]
7. Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis.
Mbeye NM; ter Kuile FO; Davies MA; Phiri KS; Egger M; Wandeler G;
Trop Med Int Health; 2014 Sep; 19(9):1057-67. PubMed ID: 25039469
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and health care resource utilization in HIV-infected children after antiretroviral therapy initiation in Côte d'Ivoire, 2004-2009.
Desmonde S; Essanin JB; Aka AE; Messou E; Amorissani-Folquet M; Rondeau V; Ciaranello A; Leroy V
J Acquir Immune Defic Syndr; 2014 Mar; 65(3):e95-103. PubMed ID: 24525473
[TBL] [Abstract][Full Text] [Related]
9. Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.
Ottichilo RK; Polyak CS; Guyah B; Singa B; Nyataya J; Yuhas K; John-Stewart G; Waitumbi JN
J Infect Dis; 2017 Jan; 215(1):88-94. PubMed ID: 28077587
[TBL] [Abstract][Full Text] [Related]
10. Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study.
Eholié SP; Ello FN; Coffie PA; Héma A; Minta DK; Sawadogo A
Trop Med Int Health; 2017 Sep; 22(9):1186-1195. PubMed ID: 28653454
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire.
Anglaret X; Messou E; Ouassa T; Toure S; Dakoury-Dogbo N; Combe P; Mahassadi A; Seyler C; N'Dri-Yoman T; Salamon R;
AIDS; 2003 Mar; 17(4):575-84. PubMed ID: 12598778
[TBL] [Abstract][Full Text] [Related]
13. Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire.
Desmonde S; Avit D; Petit J; Amorissani Folquet M; Eboua FT; Amani Bosse C; Dainguy E; Mea V; Timite-Konan M; Ngbeché S; Ciaranello A; Leroy V
PLoS One; 2016; 11(12):e0166466. PubMed ID: 27935971
[TBL] [Abstract][Full Text] [Related]
14. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
[TBL] [Abstract][Full Text] [Related]
15. The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
Walker AS; Mulenga V; Ford D; Kabamba D; Sinyinza F; Kankasa C; Chintu C; Gibb DM;
Clin Infect Dis; 2007 May; 44(10):1361-7. PubMed ID: 17443476
[TBL] [Abstract][Full Text] [Related]
16. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire.
Moh R; Danel C; Sorho S; Sauvageot D; Anzian A; Minga A; Gomis OB; Konga C; Inwoley A; Gabillard D; Bissagnene E; Salamon R; Anglaret X
Antivir Ther; 2005; 10(5):615-24. PubMed ID: 16152755
[TBL] [Abstract][Full Text] [Related]
17. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
[TBL] [Abstract][Full Text] [Related]
18. Use of non-HIV medication among people living with HIV and receiving antiretroviral treatment in Côte d'Ivoire, West Africa: A cross-sectional study.
Mama Djima M; Ekouevi DK; Gregoire JP; Tchounga B; Coffie PA; Tran VT; Touré FY; Moisan J
PLoS One; 2019; 14(9):e0221335. PubMed ID: 31525222
[TBL] [Abstract][Full Text] [Related]
19. Notification of HIV status disclosure and its related factors in HIV-infected adolescents in 2009 in the Aconda program (CePReF, CHU Yopougon) in Abidjan, Côte d'Ivoire, The PRADO-CI Study.
Meless GD; Aka-Dago-Akribi H; Cacou C; Eboua TF; Aka AE; Oga AM; Bouah B; Eugène M; Moh C; Arrivé E; Timité-Konan M; Leroy V;
J Int AIDS Soc; 2013 Jun; 16(1):18569. PubMed ID: 23782475
[TBL] [Abstract][Full Text] [Related]
20. Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study.
Kasirye RP; Baisley K; Munderi P; Levin J; Anywaine Z; Nunn A; Kamali A; Grosskurth H
AIDS; 2016 Feb; 30(4):635-44. PubMed ID: 26558729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
